COLL vs PODD · P/E 17, rev $181.9M vs P/E 34, rev $2.07B
Collegium Pharmaceutical Inc (COLL) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the COLL and PODD stock pages for the full models.
Not investment advice.